Last reviewed · How we verify

NCT05153798

Evaluation of PerioMonitor for Detection of Oral Inflammatory Load (OIL) in Human Subjects

Status unknown Last updated 10 December 2021
What this trial tests

trial in Periodontal Diseases in 117 participants. Status unknown.

Timeline
29 November 2021
Primary endpoint
31 January 2022
31 January 2022

Quick facts

Lead sponsorOral Science International Inc.
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment117
Start date29 November 2021
Primary completion31 January 2022
Estimated completion31 January 2022
Sites3 locations across Canada, United States

Conditions studied

Sponsor

Oral Science International Inc.

Who can join

18 and older, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this multicenter, prospective, single arm Study is to evaluate the efficacy and safety of PerioMonitor as an aid to the presumptive detection of oral inflammation associated with periodontal diseases. PerioMonitor is an IVD device for the rapid, semi-quantitative detection of PMN in oral samples. This test is intended for prescription use at Point-of-Care ("POC") settings by health care professionals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other Oral Science International Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05153798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing